Until recently, the association between circulating adiponectin (ADPN) levels and the risk of Alzheimer’s disease (AD) and Parkinson’s disease (PD) remained unclear. This evidence concerns the gene ADIPOQ and early-onset autosomal dominant Alzheimer disease.